NCT03987763View on ClinicalTrials.gov

A Safety and Pharmacokinetics Study of IDP-122 Lotion in Pediatric Participants With Plaque Psoriasis

PHASE4RecruitingINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

October 22, 2019

Primary Completion Date

May 31, 2026

Study Completion Date

June 30, 2026

Conditions
Psoriasis
Interventions
DRUG

IDP-122 Lotion

Topical

Trial Locations (9)

29303

TERMINATED

Bausch Site 05, Spartanburg

33125

RECRUITING

Bausch Site 3, Miami

33155

TERMINATED

Bausch Site 06, Miami

33166

RECRUITING

Bausch Site 07, Doral

91320

RECRUITING

Bausch Site 2, Thousand Oaks

92708

TERMINATED

Bausch Site 11, Fountain Valley

99216

TERMINATED

Bausch Site 1, Spokane

Unknown

RECRUITING

Bausch Site 12, Santo Domingo

TERMINATED

Bausch Site 4, Panama City

All Listed Sponsors
lead

Bausch Health Americas, Inc.

INDUSTRY